General contact

Head Office
Novartis International AG
CH-4002 Basel

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)


Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel

+41 61 324 79 44


Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.
Learn more about Targeted research Pipeline Research Approach Clinical Trials

Targeted research

accelerates the development

of medicines with potential

for great patient benefit.

Learn more

The power

of collaboration brings

innovation to life.

Learn more


As part of our commitment to patients and healthcare professionals, we have developed Alliance sites with patient support materials, educational materials, lifecycle management program information and more.
Learn more

Lifecycle Management Programs

Novartis Oncology is conducting global development initiatives for key molecules encompassing a broad range of malignancies. Learn more

Patient Advocacy

Advocacy groups help us better understand patient needs and barriers to treatment success.
Learn more

Treating cancer

and related diseases

is about supporting patients

with more than medicine.

Learn more

Patient Resources

Learn about oncology-related resources that are of interest to patients. Learn more

Patient Stories

LaDonna Lopossa
"In February of 1999, I chose the music for my own funeral. Within weeks, I got out of my wheelchair to walk on my own."
Watch her story

Global Capabilities

Unique, dedicated global capabilities support our work. Learn more

We are connected

by our passion to transform

the way patients live

with cancer worldwide.

Learn more

Our Products

Read about the cutting edge of innovative therapies and practical solutions. Learn more

Working at Novartis

Learn what it's like to work at Novartis Oncology directly from our employees. Learn more

For the Media

Get press releases and media materials related to our business, products and research & development. Learn more

Featured news